USPTO serial 76176126
GENEREX BIOTECHNOLOGY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRENCH, CURTIS W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENEREX BIOTECHNOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Generex Biotechnology Corporation
Toronto Ontario, CA
Generex Biotechnology Corporation
Toronto Ontario, CA
TORONTO, ONTARIO, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John L. DuPre
JOHN L DUPRE HAMILTON BROOK SMITH REYNOLDS PC530 VIRGINIA RDP O BOX 9133CONCORD, MA 01742-9133Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations administerable through mucous membranes for the treatment of diabetes, prostate cancer, endometriosis, breakthrough cancer pain, and for use in providing anticoagulant therapy in the treatment of heart disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Generex Biotechnology Corporation
- Other trademarks owned by Generex Biotechnology Corporation
- Other trademarks owned by GENEREX PHARMACEUTICALS INC.
- Other trademarks in Class 005
- Similar marks named GENEREX BIOTECHNOLOGY
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 22, 2008 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 22, 2008 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 28, 2007 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 6, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 13, 2007 | PAPER RECEIVED | — | |
| Apr 12, 2007 | EXT5 | SOU EXTENSION 5 FILED | — |
| Feb 15, 2007 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 2, 2006 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 2, 2006 | PAPER RECEIVED | — | |
| May 4, 2006 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 18, 2006 | PAPER RECEIVED | — | |
| Apr 12, 2006 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 15, 2005 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 30, 2005 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 30, 2005 | PAPER RECEIVED | — | |
| May 3, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 7, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 7, 2005 | PAPER RECEIVED | — | |
| Dec 23, 2004 | PAPER RECEIVED | — | |
| Oct 12, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 18, 2004 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 4, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 6, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 17, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 14, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 10, 2003 | REIN | REINSTATED | — |
| Jun 25, 2003 | PAPER RECEIVED | — | |
| Jun 13, 2003 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 10, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 8, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2001 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 17, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2001 | DOCK | ASSIGNED TO EXAMINER | — |